Kaleido BioSciences Stock
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
About Kaleido BioSciences Stock
Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.
The Boston Globe - Jun, 25 2018
Business Wire - Mar, 26 2018